ARS Pharmaceuticals, Inc. — SCHEDULE 13D/A Filings
5 SCHEDULE 13D/A filings on record
This page lists all SCHEDULE 13D/A filings submitted to the SEC by ARS Pharmaceuticals, Inc. (SPRY), sorted by most recent first. Each row links to the full filing on EdgarLookup. ARS Pharmaceuticals, Inc. has filed 5 SCHEDULE 13D/A documents with the SEC since 2016. To view all SEC filings by ARS Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-Q
10-Q/A
144
144/A
3
3/A
4
4/A
424B4
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DEFM14A
DRS
EFFECT
PREM14A
PRER14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13D/A | — | 0001346824-25-000011 | Oct 1, 2025 | — |
| SCHEDULE 13D/A | — | 0001193805-25-001146 | Aug 1, 2025 | — |
| SCHEDULE 13D/A | — | 0001193805-25-001080 | Jul 22, 2025 | — |
| SCHEDULE 13D/A | — | 0001193805-25-000963 | Jul 2, 2025 | — |
| SCHEDULE 13D/A | — | 0001193805-25-000363 | Mar 24, 2025 | — |